{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:33:46Z","timestamp":1791200026781,"version":"4.2.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.tox.2003.09.004","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T08:16:36Z","timestamp":1068884196000},"page":"179-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests"],"prefix":"10.1016","volume":"194","author":[{"given":"Dean J.","family":"Naisbitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2003.09.004_BIB1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11882-002-0035-9","article-title":"Antiepileptic hypersensitivity syndrome: clinicians beware and be aware","volume":"2","author":"Bessmertny","year":"2002","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.tox.2003.09.004_BIB2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1034\/j.1398-9995.2000.00628.x","article-title":"Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions","volume":"55","author":"Blanca","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.tox.2003.09.004_BIB3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.tox.2003.09.004_BIB4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI12118","article-title":"T-cell involvement in drug-induced acute generalised exanthematous pustulosis","volume":"107","author":"Britschgi","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2003.09.004_BIB5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4049\/jimmunol.163.2.1053","article-title":"Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions","volume":"163","author":"Brugnolo","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(89)91909-0","article-title":"Systemic glutathione deficiency in symptom-free HIV-seropositive individuals","volume":"2","author":"Buhl","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2003.09.004_BIB7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0703845","article-title":"Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells","volume":"132","author":"Burkhart","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1365-2222.2002.01513.x","article-title":"Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides","volume":"32","author":"Burkhart","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.tox.2003.09.004_BIB9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0090-9556(25)07954-1","article-title":"Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man","volume":"10","author":"Claesen","year":"1982","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2003.09.004_BIB10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0026-895X(25)09508-2","article-title":"Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs","volume":"38","author":"Cribb","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0090-9556(25)06552-3","article-title":"N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes","volume":"23","author":"Cribb","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2003.09.004_BIB12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2567.1996.d01-778.x","article-title":"Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens","volume":"89","author":"Dearman","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.tox.2003.09.004_BIB13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-1263(200005\/06)20:3<221::AID-JAT651>3.0.CO;2-#","article-title":"Characterisation in mice of the immunological properties of five allergenic acid anhydrides","volume":"20","author":"Dearman","year":"2000","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2003.09.004_BIB14","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0278-6915(02)00179-5","article-title":"Cytokine fingerprinting of chemical allergens: species comparisons and statistical analyses","volume":"40","author":"Dearman","year":"2002","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2003.09.004_BIB15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/toxsci\/71.2.137","article-title":"Chemical allergy: considerations for the practical application of cytokine profiling","volume":"71","author":"Dearman","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2003.09.004_BIB16","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.092141999","article-title":"MIP-1alpha, MIP-1beta, RANTES, and ATAC\/lymphotactin function together with IFN-gamma as type 1 cytokines","volume":"99","author":"Dorner","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tox.2003.09.004_BIB17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003088-199121010-00003","article-title":"Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance","volume":"21","author":"Eadie","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tox.2003.09.004_BIB18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/bchm3.1989.370.1.101","article-title":"Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients","volume":"370","author":"Eck","year":"1989","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.tox.2003.09.004_BIB19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0009-2797(92)90107-V","article-title":"Reactions of nitrosonitrobenzenes with biological thiols: identification and reactivity of glutathion-S-yl conjugates","volume":"82","author":"Ellis","year":"1992","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2003.09.004_BIB20","unstructured":"Engler, O., Strasser, I., Naisbitt, D.J., Cerny, A., Pichler, W.J. A chemically inert drug can stimulate T-cells in vitro by their T-cell receptor and induce cytokine secretion, proliferation and cytotoxicity, submitted for publication."},{"key":"10.1016\/j.tox.2003.09.004_BIB21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.103.050112","article-title":"Characterisation of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and man","volume":"306","author":"Farrell","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2003.09.004_BIB22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archderm.1994.01690050066011","article-title":"Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine","volume":"130","author":"Friedmann","year":"1994","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2003.09.004_BIB24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(24)36867-3","article-title":"The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat","volume":"282","author":"Gill","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2003.09.004_BIB25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1615\/CritRevImmunol.v21.i5.30","article-title":"Induction and regulation of T-cell priming for contact hypersensitivity","volume":"21","author":"Gorbachev","year":"2001","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0192-0561(94)90090-6","article-title":"T-cell adjuvants","volume":"16","author":"Hadden","year":"1994","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB27","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","article-title":"T cell involvement in cutaneous drug eruptions","volume":"31","author":"Hari","year":"2001","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.tox.2003.09.004_BIB28","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.4049\/jimmunol.168.10.5359","article-title":"Characterisation of drug-specific T cells in phenobarbital-induced eruption","volume":"168","author":"Hashizume","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.1995.tb05016.x","article-title":"CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes","volume":"132","author":"Hertl","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0090-9556(25)08567-8","article-title":"Metabolism of isoniazid by activated leukocytes. Possible role in drug-induced lupus","volume":"20","author":"Hofstra","year":"1992","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2003.09.004_BIB31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nm0202-157","article-title":"CCL27-CCR10 interactions regulate T cell-mediated skin inflammation","volume":"8","author":"Homey","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2003.09.004_BIB32","first-page":"41","article-title":"Exposure of mice to sulfamethoxazole metabolite stimulates IL-5 expression","volume":"178","author":"Hopkins","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2003.09.004_BIB33","first-page":"444","article-title":"Distribution of antigen formation: a determinant of the nature of a cellular immune response to simple chemicals","volume":"55","author":"Hopkins","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S0317167100021880","article-title":"Cross sensitivity of skin rashes with antiepileptic drugs","volume":"24","author":"Hyson","year":"1997","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.tox.2003.09.004_BIB35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nature01076","article-title":"Direct observation of ligand recognition by T cells","volume":"419","author":"Irvine","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tox.2003.09.004_BIB36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0006-2952(01)00718-3","article-title":"Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450","volume":"62","author":"Janmohamed","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(24)37923-6","article-title":"Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate","volume":"288","author":"Ju","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2003.09.004_BIB38","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinte.144.8.1677","article-title":"Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital","volume":"144","author":"Kahn","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tox.2003.09.004_BIB39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2133.2003.05066.x","article-title":"High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid","volume":"148","author":"Kakinuma","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB40","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0190-9622(95)90351-8","article-title":"Antigen processing: the gateway to the immune response","volume":"32","author":"Kalish","year":"1995","journal-title":"Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0091-6749(99)70489-6","article-title":"Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity","volume":"103","author":"Kalish","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(25)24104-0","article-title":"Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane","volume":"245","author":"Kenna","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2003.09.004_BIB43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1567-5769(01)00173-4","article-title":"Allergic contact dermatitis","volume":"2","author":"Kimber","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3565(24)35100-6","article-title":"Metabolism of trimethoprim to a reactive iminoquinone methide by activated human neutrophils and hepatic microsomes","volume":"291","author":"Lai","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2003.09.004_BIB45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.61.5.643","article-title":"Studies on the sensitization of animals with simple chemical compounds","volume":"61","author":"Landsteiner","year":"1935","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tox.2003.09.004_BIB46","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1528-1157.1998.tb01679.x","article-title":"Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs","volume":"39","author":"Leeder","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.tox.2003.09.004_BIB47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0091-6749(00)90191-X","article-title":"Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response","volume":"105","author":"Leyva","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-9556(25)07375-1","article-title":"Bioactivation of carbamazepine in the rat in-vivo\u2014evidence for the formation of reactive arene oxide(s)","volume":"24","author":"Madden","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2003.09.004_BIB49","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/tx0000825","article-title":"Metabolism of lamotrigine to a reactive arene oxide intermediate","volume":"13","author":"Maggs","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2003.09.004_BIB50","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/mol.62.5.1011","article-title":"Haptenation of sulfonamide reactive metabolites to cellular proteins","volume":"62","author":"Manchanda","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch Intern. Med."},{"key":"10.1016\/j.tox.2003.09.004_BIB52","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.155.1.462","article-title":"Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine","volume":"155","author":"Mauri-Hellweg","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-0536.2000.042003123.x","article-title":"Contact allergy, irritancy and \u2018danger\u2019","volume":"42","author":"McFadden","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tox.2003.09.004_BIB55","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1021\/tx9700836","article-title":"Bioactivation of phenytoin by human cytochrome P450: characterisation of the mechanism and targets of covalent adduct formation","volume":"10","author":"Munns","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2003.09.004_BIB56","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0960-894X(96)00260-0","article-title":"Synthesis and reactions of nitroso sulfamethoxazole with biological nucleophiles\u2014implications for immune-mediated toxicity","volume":"6","author":"Naisbitt","year":"1996","journal-title":"Bioorg. Med. Chem. Let."},{"key":"10.1016\/j.tox.2003.09.004_BIB57","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702453","article-title":"Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity","volume":"126","author":"Naisbitt","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200023060-00002","article-title":"Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment","volume":"23","author":"Naisbitt","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2003.09.004_BIB59","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/088922200750054657","article-title":"Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection","volume":"16","author":"Naisbitt","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.tox.2003.09.004_BIB60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00130832-200108000-00007","article-title":"Reactive metabolites and their role in drug reactions","volume":"1","author":"Naisbitt","year":"2001","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","article-title":"Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo","volume":"133","author":"Naisbitt","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB62","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation","volume":"62","author":"Naisbitt","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-003-0006-9","article-title":"Immunopharmacology of hypersensitivity reactions to drugs","volume":"3","author":"Naisbitt","year":"2003","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.tox.2003.09.004_BIB64","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine: characterisation of the specificity, phenotype, and cytokine profile of drug-specific T cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB65","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterisation of drug-specific T-cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB66","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0009-9120(00)00146-6","article-title":"A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes","volume":"33","author":"Neuman","year":"2000","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tox.2003.09.004_BIB68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/bbrc.1999.0525","article-title":"Oxidative DNA damage by a metabolite of carcinogenic and reproductive toxic nitrobenzene in the presence of NADH and Cu(II)","volume":"257","author":"Ohkuma","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tox.2003.09.004_BIB69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/00970002042006004","article-title":"Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity","volume":"42","author":"O\u2019Neil","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2003.09.004_BIB70","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/03602539408998319","article-title":"Effects of fluorine substitution on drug metabolism: pharmacological and toxicological implications","volume":"26","author":"Park","year":"1994","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tox.2003.09.004_BIB71","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/tx980058f","article-title":"Role of drug disposition in drug hypersensitivity: a chemical, molecular and clinical perspective","volume":"9","author":"Park","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2003.09.004_BIB72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0300-483X(00)00397-8","article-title":"Metabolic activation in drug allergies","volume":"158","author":"Park","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2003.09.004_BIB73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00128071-200203040-00001","article-title":"Cellular and molecular pathophysiology of cutaneous drug reactions","volume":"3","author":"Pichler","year":"2002","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB74","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00130832-200108000-00006","article-title":"HIV and drug allergy","volume":"1","author":"Pirmohamed","year":"2001","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00008571-200011000-00005","article-title":"Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity","volume":"10","author":"Pirmohamed","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.tox.2003.09.004_BIB76","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1747.2000.00985.x","article-title":"A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions","volume":"114","author":"Reilly","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0145-305X(02)00160-X","article-title":"Evolution of heat shock protein and immunity","volume":"27","author":"Robert","year":"2003","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000245690","article-title":"Lamotrigine-induced Stevens Johnson syndrome: demonstration of specific lymphocyte reactivity in vitro","volume":"195","author":"Sachs","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.tox.2003.09.004_BIB79","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0002-9440(10)64486-0","article-title":"Acute generalised exanthematous pustulosis: role of cytotoxic T cells in pustule formation","volume":"161","author":"Schmid","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2003.09.004_BIB80","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2003.09.004_BIB81","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.tox.2003.09.004_BIB82","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB83","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4049\/jimmunol.166.2.996","article-title":"Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity","volume":"166","author":"Sebastiani","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB84","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00403-001-0276-9","article-title":"The role of chemokines in allergic contact dermatitis","volume":"293","author":"Sebastiani","year":"2002","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.tox.2003.09.004_BIB85","first-page":"595","article-title":"Clinical spectrum of drug rashes due to antiepileptics","volume":"46","author":"Sharma","year":"1998","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.tox.2003.09.004_BIB86","doi-asserted-by":"crossref","first-page":"14590","DOI":"10.1073\/pnas.260497597","article-title":"Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses","volume":"97","author":"Shi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tox.2003.09.004_BIB87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalised exanthematous pustulosis (AGEP)\u2014a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.tox.2003.09.004_BIB88","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2002-07-2348","article-title":"CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking","volume":"101","author":"Soler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tox.2003.09.004_BIB89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0009-2797(02)00060-1","article-title":"Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells","volume":"142","author":"Summan","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2003.09.004_BIB90","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","article-title":"Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome","volume":"134","author":"Suzuki","year":"1998","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB91","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5414\/CPP38452","article-title":"Development of a pulmonary phenytoin-associated hypersensitivity reaction despite concomitant dexamethasone and prednisolone administration","volume":"38","author":"Troger","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2003.09.004_BIB92","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(25)20618-8","article-title":"Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide","volume":"232","author":"Uetrecht","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2003.09.004_BIB93","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx980249i","article-title":"New concepts in immunology relevant to idiosyncratic drug reactions: the \u201cdanger hypothesis\u201d and innate immune system","volume":"12","author":"Uetrecht","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2003.09.004_BIB94","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.4049\/jimmunol.165.4.1725","article-title":"Cutting edge: cutting edge commentary: a Copernican revolution? Doubts about the danger theory","volume":"165","author":"Vance","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB95","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/00002030-199714000-00005","article-title":"Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications","volume":"11","author":"Walmsley","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.tox.2003.09.004_BIB96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0009-2797(02)00059-5","article-title":"The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes","volume":"142","author":"Walsh","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2003.09.004_BIB97","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/1389200023337423","article-title":"Are chemically reactive metabolites responsible for adverse reactions to drugs?","volume":"3","author":"Williams","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tox.2003.09.004_BIB98","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/tx000214u","article-title":"T cells ignore aniline, a prohapten, but respond to its reactive metabolites generated by phagocytes: possible implications for the pathogenesis of toxic oil syndrome","volume":"14","author":"Wulferink","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2003.09.004_BIB99","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1747.2000.00105.x","article-title":"T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic","volume":"115","author":"Yawalkar","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","article-title":"Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions","volume":"106","author":"Yawalkar","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0091-6749(88)90059-0","article-title":"In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10,11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity","volume":"82","author":"Zakrzewska","year":"1988","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB102","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.158.3.1139","article-title":"Characterisation of lidocaine-specific T cells","volume":"158","author":"Zanni","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.09.004_BIB103","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI3544","article-title":"HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes","volume":"102","author":"Zanni","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2003.09.004_BIB104","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1523-1747.2000.00999.x","article-title":"Chemical activation of innate and specific immunity in contact dermatitis","volume":"115","author":"Zhang","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tox.2003.09.004_BIB105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/smim.2000.0253","article-title":"Localization dose and time of antigens determine immune reactivity","volume":"12","author":"Zinkernagel","year":"2000","journal-title":"Semin. Immunol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X03004165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X03004165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:46:51Z","timestamp":1759531611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X03004165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0300483X03004165"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2003.09.004","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2003.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}